Image
Accomplishments
Côte d’Ivoire has been conducting annual mass drug administration (MDA) to eliminate lymphatic filariasis in all 99 endemic districts since 2016. In 2021, all endemic districts successfully completed at least five high coverage MDA and are currently conducting impact assessment surveys to determine improvement in infection prevalence and interruption of transmission of the causative parasite.
Although baseline mapping for trachoma only started in 2015, 60% of all districts in the country have now been mapped. 49% have already completed their MDA rounds as of FY21 (October 2020 – September 2021).
Standard Disease-Specific Indicators as of FY20
FY20 is October 2019 through September 2020
LYMPHATIC FILARIASIS
In FY20, no endemic districts that were still undergoing treatment conducted MDA due to COVID-19 constraints. However, in FY20, 46 out 99 endemic districts that had already completed five rounds of MDA conducted a survey (pre-TAS) to determine if they could progress to a stop-MDA survey (TAS1).
TRACHOMA
of ever-endemic districts have stopped MDA as of FY20
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))*
* Roughly 50% of districts not yet mapped for Trachoma
of ever-endemic districts in post-surveillance phase as of FY20
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))
of persons no longer at risk as of FY20 among those who were ever at risk.
Onchoceriasis
of ever endemic districts have been treated at least once as of FY20
Schistosomiasis*
of ever endemic districts have been treated at least once as of FY20
*SCH is not supported by USAID
SOIL-TRANSMITTED Helminthiasis*
of ever endemic districts have been treated at least once as of FY20
*STH is not supported by USAID